Veterinary Medicines

AMPROLINE 400 MG/ML SOLUTION FOR USE IN DRINKING WATER FOR CHICKENS AND TURKEYS

Authorised
  • Amprolium hydrochloride
Download as PDF

Product identification

Medicine name:
AMPROLINE 400 MG/ML SOLUTION FOR USE IN DRINKING WATER FOR CHICKENS AND TURKEYS
Amproline 400 mg/ml Oplossing voor gebruik in drinkwater
Amproline 400 mg/ml Solution pour administration dans l'eau de boisson
Amproline 400 mg/ml Lösung zum Eingeben über das Trinkwasser
Active substance:
  • Amprolium hydrochloride
Target species:
  • Turkey
  • Chicken (pullet for egg production, future layer)
  • Chicken (for reproduction)
  • Chicken (broiler)
  • Chicken (layer hen)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Amprolium hydrochloride
    452.40
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for use in drinking water
Withdrawal period by route of administration:
  • Oral use
    • Turkey
      • Eggs
        0
        day
      • Meat and offal
        0
        day
    • Chicken (pullet for egg production, future layer)
      • Eggs
        0
        day
      • Meat and offal
        0
        day
    • Chicken (for reproduction)
      • Eggs
        0
        day
      • Meat and offal
        0
        day
    • Chicken (broiler)
      • Meat and offal
        0
        day
    • Chicken (layer hen)
      • Eggs
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51AX09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • 1 L can
  • 5 L can
  • 100 mL can

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Huvepharma S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Huvepharma S.A.
  • Biovet AD
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0284/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Czechia
  • Denmark
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 9/12/2024
Download
French (PDF)
Published on: 9/12/2024
Download
German (PDF)
Published on: 9/12/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 9/12/2024
Download
French (PDF)
Published on: 9/12/2024
Download
German (PDF)
Published on: 9/12/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 9/12/2024
Download
French (PDF)
Published on: 9/12/2024
Download
German (PDF)
Published on: 9/12/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."